Scoping Review Protocol: Mapping Psilocybin Therapy Research

Thumbnail Image
Shore, Ron
Ioudovski, Paul
McKeown, Sandra
Dumont, Eric
Goldie, Craig
psilocybin , psychedelics , clinical trial , mental health therapy , addiction , depression , scoping review
Objective: By understanding the patients selected, the interventions used, and the outcomes noted for psilocybin-assisted therapies, we may better understand the program variables and best practices of these emerging treatments. This scoping review will extract, review and chart data related to psilocybin-assisted therapy in three domains. 1. Patients — cohort size, presenting conditions, 2. Interventions — location, dosage, ancillary services 3. Outcomes — changes, indications, conclusions Through librarian-conducted literature searches and defined inclusion criteria, the relevant number of internationally published, peer-reviewed academic articles in addition to grey area literature will be identified, and the findings charted to identify the current state of both the literature and this treatment modality.
External DOI